[{"NetIncomeLossConverted_12_FY_USD":-646300000.0,"NetIncomeLossConverted_4_FY_USD":-250221000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-115093000.0,"CommonStockSharesOutstanding_0_FY_shares":140474305.0,"StockholdersEquity_0_FY_USD":1079617000.0,"EarningsPerShareBasic_4_FY_USD":-2.08,"Assets_0_FY_USD":1227829000.0,"CommonStockSharesConverted_0_FY_shares":140474305.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"12","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210225"}]